Abstract:Background and Aims: Collagen beta(1-O) galactosyltransferase 25 domain 1 (GLT25D1) is associated with collagen production and glycosylation, and its knockout in mice results in embryonic death. However, its role in liver fibrosis remains elusive, particularly in hepatic stellate cells (HSCs), the primary collagen-producing cells associated with liver fibrogenesis. Herein, we aimed to elucidate the role of GLT25D1 in HSCs. Methods: Bile duct ligation (BDL)-induced mouse liver fibrosis models, primary mouse HSCs (mHSCs), and transforming growth factor beta 1 (TGF-beta 1)-stimulated LX-2 human hepatic stellate cells were used in in vivo and in vitro studies. Stable LX-2 cell lines with either GLT25D1 overexpression or knockdown were established using lentiviral transfection. RNA-seq was performed to investigate the genomic differences. HPLCMS/MS were used to identify glycosylation sites. Scanning electronic microscopy (SEM) and second-harmonic generation/two-photon excited fluorescence (SHG/TPEF) were used to image collagen fibril morphology. Results: GLT25D1 expression was upregulated in nonparenchymal cells in human cirrhotic liver tissues. Meanwhile, its knockdown attenuated collagen deposition in BDL-induced mouse liver fibrosis and inhibited mHSC activation. GLT25D1 was overexpressed in activated versus quiescence LX-2 cells and regulated in vitro LX-2 cell activation, including proliferation, contraction, and migration. GLT25D1 also significantly increased liver fibrogenic gene and protein expression. GLT25D1 upregulation promoted HSC activation and enhanced collagen expression through the TGF-beta 1/SMAD signaling pathway. Mass spectrometry showed that GLT25D1 regulated the glycosylation of collagen in HSCs, affecting the diameter of collagen fibers. Conclusions: Collectively, the upregulation of GLT25D1 in HSCs promoted the progression of liver fibrosis by affecting HSCs activation and collagen stability.

[Function of TTG1A in Hepatic Stellate Cells].

DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis.

Tissue Transglutaminase, a Key Enzyme Involved in Liver Diseases.

Inflammatory cytokine mediated expression of tissue transglutaminase in tissue fibrosis

Characterization and Sub-cellular Localization of GalNAc-Binding Proteins Isolated from Human Hepatic Stellate Cells.

Alteration of Protein Glycosylation in Human Hepatic Stellate Cells Activated with Transforming Growth Factor-Β1.

Biglycan promotes hepatic fibrosis through activating heat shock protein 47

Screening and Cloning Genes Transactivated by TGF Beta 1 in Hepatic Stellate Cells Using Suppression Subtractive Hybridization Technique

Upregulation of GLT25D1 in Hepatic Stellate Cells Promotes Liver Fibrosis Via the TGF-β1/SMAD3 Pathway in Vivo and in Vitro

Telocytes in Human Liver Fibrosis.

Down-regulation of Ttg Expression by RNAi Inhibits HSC Proliferation and Attenuates Liver Fibrosis.

[Tissue Transglutaminase and Renal Fibrosis].

Screening and cloning of down-regulated genes transactivated by transforming growth factor β_1 in hepatic stellate cells

[Effects of Tumor Necrosis Factor Alpha on the Expression of Connective Tissue Growth Factor in Hepatic Stellate Cells].

LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis

Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells.

CAT1 Silencing Inhibits TGF-β1-induced Mouse Hepatic Stellate Cell Activation in Vitro and Hepatic Fibrosis in Vivo.

Glial Cell Line-Derived Neurotrophic Factor (GDNF) Mediates Hepatic Stellate Cell Activation Via ALK5/Smad Signalling

Effects of A94T and P84L Polymorphisms Within the TNF-α Gene on Proliferation and Activation of Hepatic Stellate Cells.

Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses.

TGF-β1 Signaling Regulates Mouse Hepatic Stellate Cell Differentiation Via the Jagged1/Notch Pathway.